A Study of Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric Cancer

NCT02563054 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

316

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: 5-Fluorouracil
DRUG: Capecitabine
DRUG: Cisplatin

Sponsor

Hoffmann-La Roche